Fatma Peyman ERTUĞ

Dr. Fatma Peyman ERTUĞ

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
FEFatma Peyman ERTUĞ
Fatma Peyman ERTUĞ
EŞErğin ŞİNGİRİK
Erğin ŞİNGİRİK
HBHacer Sinem Büyüknacar
Hacer Sinem Büyüknacar
CGCemil Göçmen
Cemil Göçmen
MSMehmet Ata Seçi̇lMi̇ş
Mehmet Ata Seçi̇lMi̇ş
Background/aim: To investigate the effects of spermine NONOate in the cavernous tissue obtained from mice treated or untreated with sildenafil. Materials and methods: We studied the effects of spermine NONOate on the tone and nitrergic relaxation responses of isolated mouse corpus cavernosum and compared them with sodium nitroprusside in the absence or presence of L-nitroarginine, hydroxocobalamin, pyrogallol, diethyldithiocarbamate (DETCA), or 1H-[1,2,4] Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). The neurogenic contractions and relaxations of the tissues were induced by electrical field stimulation. Some mice received a single oral dose of sildenafil and after 1 h the effects of spermine NONOate were evaluated by in vitro studies. Results: Spermine NONOate relaxed mouse corpus cavernosum in a concentration-dependent manner. Spermine-NONOate-induced relaxation was relatively slow to develop and it was reversible and reproducible. These relaxations were significantly suppressed by hydroxocobalamin, diethyldithiocarbamate, or ODQ, but not by L-nitroarginine or pyrogallol. Spermine NONOate potentiated the nitrergic relaxations to electrical field stimulation (EFS), whereas it significantly reduced EFS-induced contractions. Sildenafil treatment can enhance the relaxant responses to spermine NONOate and EFS. Conclusion: These findings suggest that spermine NONOate has a potent relaxant action in cavernous tissue and this effect can be potentiated by oral sildenafil treatments. Spermine NONOate may be considered an attractive treatment for erectile dysfunction in pathologic disorders with a lack of endogenous NO production.

20 March 2010 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
FEFatma Peyman ERTUĞ
Fatma Peyman ERTUĞ
AOAnil A. Olguner
Anil A. Olguner
NÖNuran Öğülener
Nuran Öğülener
EŞErgin Şingirik
Ergin Şingirik

30 June 2024 in Arşiv Kaynak Tarama Dergisi
Verified
Journal Article
Open access
PDF file
FEFatma Peyman ERTUĞ
Fatma Peyman ERTUĞ
SGSedef Gidener
Sedef Gidener
Hamilelik sırasında bitkisel ürünlerin çok yaygın kullanımına rağmen, bu tedavilerin spesifik olarak değerlendirilmesine yönelik çok az çalışma bulunmaktadır. Hiperemezis gravidarum için zencefil takviyesi dışında, aslında hamile kadınlarda başka herhangi bir bitkisel tedavinin kullanımı için klinik bir endikasyon yoktur. Aksine, vaka raporları ve epidemiyolojik çalışmalardan elde edilen kısıtlı sayıdaki veriler, bazı bileşiklerin kullanımına ilişkin uyarılara sahiptir. Bitkilerin hamilelik veya doğum üzerinde etkileri olabilir, reçeteli ilaçlarla etkileşimleri olabilir ve fetüs için potansiyel olarak ciddi komplikasyonlara neden olabilir. Bu nedenle özellikle hamilelikte bitkisel ilaç öyküsü almak önemlidir.

31 December 2024 in Arşiv Kaynak Tarama Dergisi
Verified
Journal Article
Open access
PDF file
FEFatma Peyman ERTUĞ
Fatma Peyman ERTUĞ
SESerkan Ecemiş
Serkan Ecemiş
Opioid kullanım bozukluğu dünyada önemli bir şekilde morbidite ve mortalite kaynağı olmaya devam etmektedir. Farmakoterapi, opioid yoksunluk semptomlarını hafifletmek, nüksetmeyi azaltmak ve uzun vadeli iyileşmeyi sağlamak amacıyla opioid kullanım bozukluğunun tedavisinde önemli rol oynamaktadır. Metadon, buprenorfin, nalokson, naltrekson, klonidin ile yapılan tedavilerin, opioid kullanım bozukluğunu düzeltmede, bağımlılığın tedavisinde ve aşırı dozdan ölümleri azaltmada etkili olduğu gösterilmiştir. Bu derlemede, opioid bağımlılığının biyolojik mekanizmaları, opioid kullanım bozukluğunun tedavisinde kullanılan farmakolojik ajanların farmakokinetiği, farmakodinamiği, endikasyonları ve yan etkileri hakkında bilgi verilmektedir.

14 October 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
GÖGazihan Harun Özsayın
Gazihan Harun Özsayın
ÖYÖzlem Yorulmaz-Özü
Özlem Yorulmaz-Özü
UGUmay Merve Merve Güven Güven
Umay Merve Merve Güven Güven
SKSerpil Demirci Kayiran
Serpil Demirci Kayiran
YKYURDUN KUYUCU
YURDUN KUYUCU
MSMehmet Ata Seçilmiş
Mehmet Ata Seçilmiş
Gentamicin is an aminoglycoside antibiotic and has therapeutic importance in the treatment of Gram-negative aerobic bacterial infections. However, its clinical use is limited by nephrotoxicity, in which oxidative stress plays an important role. In this study, we investigated the protective effects of Cyclotrichium niveum, an endemic plant with antioxidant properties, against gentamicin-induced nephrotoxicity in rats. Renal injury and protection were assessed using blood urea nitrogen (BUN) and serum creatinine as markers of renal function, malondialdehyde (MDA) as a marker of oxidative stress, and histopathological evaluation of renal cortical injury. We first characterized the chemical composition of C. niveum essential oil (EO) by GC-MS, identifying pulegone as its major constituent (79.6%). Next, we evaluated the in vitro antioxidant activity of EO and isolated pulegone using the DPPH assay. Their protective effects were then examined in vivo at two dose levels each (EO, 200 and 400 mg/kg/day; pulegone, 50 and 100 mg/kg/day, p.o.) in rats receiving gentamicin (100 mg/kg/day, i.m.) for 8 days. Both EO and pulegone exhibited DPPH radical-scavenging activity. Gentamicin induced pronounced renal injury, whereas co-administration of either EO or pulegone provided protection, with more pronounced effects at the higher doses. In particular, gentamicin increased BUN and creatinine 2.74- and 2.37-fold, respectively (p < 0.001 for both), and produced grade 4–5 cortical injury in all histologically evaluated animals. At the higher doses, EO and pulegone reduced BUN by 56% and 64%, respectively (p = 0.042 and p < 0.001), and MDA by 57% and 55%, respectively (p = 0.006 for both). Pulegone additionally reduced creatinine by 39% (p = 0.041). Both treatments significantly improved histopathological injury grade (p = 0.002 and p = 0.008 for EO and pulegone, respectively). Together, these findings demonstrate that C. niveum EO and pulegone attenuate gentamicin-induced renal injury across functional, oxidative, and structural measures, with the strongest protection observed at the higher doses. Their in vitro antioxidant activity and attenuation of lipid peroxidation in vivo support an antioxidant contribution to the nephroprotective response, while the activity of isolated pulegone identifies it as an important bioactive contributor to the protective effects of C. niveum EO.